Publications by authors named "Michael Bowsher"

Claim this Profile
P
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold.
Eric P Gillis, Kyle Parcella, Michael Bowsher, James H Cook, Christiana Iwuagwu

J Med Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor.
Kyle Parcella, Tao Wang, Kyle Eastman, Zhongxing Zhang, Zhiwei Yin, Michael Bowsher

ACS Med Chem Lett· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection.
Li-Qiang Sun, Eric Mull, Stanley D'Andrea, Barbara Zheng, Sheldon Hiebert, Michael Bowsher

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease.
Michael Bowsher, Sheldon Hiebert, Rongti Li, Alan X Wang, Jacques Friborg

Bioorg Med Chem Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ generation of o-iodoxybenzoic acid (IBX) and the catalytic use of it in oxidation reactions in the presence of Oxone as a co-oxidant.
Arun P Thottumkara, Michael S Bowsher, Thottumkara K Vinod

Org Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis